Font Size: a A A
Keyword [EGFR-TKI]
Result: 181 - 200 | Page: 10 of 10
181. The Mechanism Underlying The Effects Of A New Oncology Candidate Compound FHND004 On The Cardiac HERG Potassium Channels
182. Restricting Glutamine Uptake Enhances NSCLC Sensitivity To Third-generation EGFR-TKI HS10296
183. Analysis Of The Effect Of EGFR-TKI And Platinum Containing Chemotherapy On The Preoperative Stage Of ? B Lung Adenocarcinoma In Qinghai
184. Analysis Of EGFR T790M Mutation Rate And Related Characteristics After First-line Treatment Of Advanced Non-small Cell Lung Cancer With Sensitive Mutations
185. Clinical Study Of Xiaoxuanming Decoction Combined With EGFR-TKI In The Treatment Of Advanced Non-small Cell Lung Cancer(Yang Deficiency And Cold Coagulation,Qi And Blood Deficiency Type)
186. A Retrospective Analysis Of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors (EGFR-TKIs) With Or Without Chemotherapy For Advanced Lung Adenocarcinoma
187. Clinical Efficacy And Influence Factors Of Icotinib Combined With Chemotherapy In The Treatment Of Advanced Lung Adenocarcinoma With EGFR Sensitive Mutations
188. The Predictive Value Of Tumor Mutational Burden In EGFR-mutant Advanced Non-small Cell Lung Cancer Treated With EGFR-TKI
189. The Clinical Observation Of Bufeixiaoji Decoction Combined With EGFR-TKI In The Treatment Of Advanced Non-small Cell Lung Cancer
190. Identification And Functional Study Of Acquired Resistance Markers Of Third-generation EGFR-TKI Osimertinib
191. Osteopontin Contributes To Acquired Resistance In Lung Adenocarcinoma Cells Through The Integrin/FAK Signalling Pathway
192. Experimental Study On EGFR-TKI Resistant Non-Small Cell Lung Cancer With Antiangiogenic Drugs
193. Study On The Relationship Between Vascular Mimicry And Therapeutic Response And Prognosis In EGFR Mutant Lung Adenocarcinoma
194. Meta-analysis Of Traditional Chinese Medicine Intervention In EGFR-TKI Ralated Rash
195. Effect Of EGFR-TKI Treatment On The Prognosis Of Stage ? Lung Adenocarcinoma With Chronic Obstructive Pulmonary Disease With High Secretion Of Sputum And Mucus
196. Observation On The Efficacy Of Three Treatment Options For T790M Negative Advanced NSCLC Patients After First Generation EGFR-TKIs Resistance
197. Clinical Observation Of EGFR-TKI Combined With 89sr In The Treatment Of Non-small Cell Lung Cancer With Osteoblastic Reaction
198. A Clinical Study Of Xiaofeng Powder In The Treatment Of Non-small Cell Lung Cancer EGFR-TKI-related Damp-heat Rash
199. Professor Yingxu Hao's Experience In The Treatment Of Non-small Cell Lung Cancer EGFR-TKIs-related Diarrhea In Traditional Chinese Medicine
200. A role for lipid rafts in EGFR TKI resistance in breast cancer
  <<First  <Prev  Next>  Last>>  Jump to